文献
J-GLOBAL ID:202002217530650879
整理番号:20A0149452
日本人患者における再発性,進行性尿路上皮癌に対するペムブロリズマブ対化学療法:第3相KEYNOTE-045 試験のサブグループ分析
Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial
著者 (17件):
Nishiyama Hiroyuki
(University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan)
,
Yamamoto Yoshiaki
(Yamaguchi University Hospital, Ube, Japan)
,
Sassa Naoto
(Nagoya University Hospital, Nagoya, Japan)
,
Nishimura Kazuo
(Osaka International Cancer Institute, Osaka, Japan)
,
Fujimoto Kiyohide
(Nara Medical University Hospital, Kashihara, Japan)
,
Fukasawa Satoshi
(Chiba Cancer Center, Chiba, Japan)
,
Yokoyama Minato
(Medical Hospital, Tokyo Medical and Dental University, Tokyo, Japan)
,
Enokida Hideki
(Kagoshima University Hospital, Kagoshima, Japan)
,
Takahashi Kenichi
(MSD K.K., Kitanomaru Square, Tokyo, Japan)
,
Tanaka Yoshinobu
(MSD K.K., Kitanomaru Square, Tokyo, Japan)
,
Imai Kentaro
(Merck & Co., Inc., Kenilworth, NJ, USA)
,
Shimamoto Takashi
(MSD K.K., Kitanomaru Square, Tokyo, Japan)
,
Perini Rodolfo
(Merck & Co., Inc., Kenilworth, NJ, USA)
,
Frenkl Tara
(Merck & Co., Inc., Kenilworth, NJ, USA)
,
Bajorin Dean
(Memorial Sloan Kettering Cancer Center, New York, NY, USA)
,
Bellmunt Joaquim
(PSMAR-IMIM Research Institute, Barcelona, Spain)
,
Bellmunt Joaquim
(Harvard Medical School, Boston, MA, USA)
資料名:
International Journal of Clinical Oncology (Web)
(International Journal of Clinical Oncology (Web))
巻:
25
号:
1
ページ:
165-174
発行年:
2020年
JST資料番号:
U1599A
ISSN:
1341-9625
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)